Search

Your search keyword '"Zucman-Rossi J"' showing total 535 results

Search Constraints

Start Over You searched for: Author "Zucman-Rossi J" Remove constraint Author: "Zucman-Rossi J"
535 results on '"Zucman-Rossi J"'

Search Results

4. Prognostic impact of clear cell renal cell carcinoma molecular subtypes determined on formalin-fixed paraffin-embedded tissue samples on outcome after complete surgical metastasectomy

7. 686P Angiogenesis related blood biomarkers of response to checkpoint inhibitors (IO) and VEGFR-TKI in metastatic renal cell carcinoma (mRCC): Results from the BIONIKK prospective trial

8. 689P Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

10. Contributors

15. New insights in the management of Hepatocellular Adenoma

18. LBA25 Results from the phase II biomarker driven trial with nivolumab (N) and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer (m-ccRCC) patients (pts): The BIONIKK trial

19. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases

23. cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation

24. Advanced clear-cell renal cell carcinoma (accRCC): Association of microRNAs (miRNAs) with molecular subtypes, mRNA targets and outcome

25. miR-193a-5 p regulates NUSAP1 expression to suppress hepatocarcinogenesis

27. Tumor molecular characteristics in patients (pts) with international metastatic renal cell carcinoma database consortium (IMDC) good (G) and intermediate/poor (I/P) risk

29. AAV2 viral infection in liver and tumor development

31. Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance

33. EASL Clinical Practice Guidelines on the management of benign liver tumours

34. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report

35. Molecular subtypes of metastatic clear-cell renal cell carcinoma are associated with outcome after metastasectomy with curative intent

37. Recurrent INHBE-GLI1 fusions in hepatocellular adenomas with sonic hedgehog pathway activation

39. Genotype-Phenotype Correlation of CTNNB1 Mutations Reveals Different B-Catenin Activation Levels in Hepatocellular Tumors with High Activity Associated with Malignancy

41. Prospective Evidence That Hepatocellular Carcinoma Surveillance in Patients with Compensated Viral Cirrhosis Increases the Probability of Curative Treatment and Survival Taking into Account Lead-Time Bias (Anrs Co12 Cirvir Cohort)

42. Nosology and Molecular Classification of Hepatocellular Adenomas

45. FRI-141 - Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance

49. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs

Catalog

Books, media, physical & digital resources